Axogen, Inc. — Director's Dealing 2014

Jun 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-06-02

Reporting Person: Freitag Gregory Gene (Director, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-02	Common Stock	P	5000	$2.45	Acquired	29318	Direct
2014-06-03	Common Stock	P	200	$2.34	Acquired	29518	Direct

Footnotes

F1: These shares were purchased in the open market